On Entheogenic Practitioner Duties and Privileges under Oregon’s 109 Program

Below is my formal comment I submitted to the OHA.  Please email publichealth.rules@dhsoha.state.or.us to submit your own written comment by 5:00 p.m. PDT on April 21, and if you can, also sign up to make direct verbal comments on April 18 and 21.  Also, please click this link to join an event the Portland Psychedelics Society is hosting at 6:00 p.m.

Continue Reading

Natural Medicine Colorado: Combining Regulated and Community Healing Models

I’ve been waiting for the dust to settle to publish this blog regarding the Natural Medicine Health Act (NMHA), the ballot measure filed by Natural Medicine Colorado.¹ I see what the NMHA does as one seamless policy: making natural medicines—psychedelic plant and fungal medicines containing psilocybin, DMT, ibogaine or mescaline (excepting peyote)—available to all adult Coloradans in two powerful healing modalities: via a regulated access model in a therapeutic context;

Continue Reading

Dr. Bronner’s to Provide Psychedelic-Therapy as Employee Healthcare Benefit

First Ever Partnership between Health Plan Administrator and Leading U.S. Company to Offer Employee Coverage for Ketamine-Assisted Therapy to Promote Mental Health Dr. Bronner’s has expanded its mental healthcare benefits to include ketamine-assisted therapy, as a first step in providing access to psychedelic-assisted therapy to employees to promote mental health. This innovative benefit plan is administered by Enthea,

Continue Reading

Keeping What’s Sacred, Sacred Through Unity

Help preserve sacred Peyote medicine and strengthen the Indigenous sovereignty of traditional medicine keepers—contribute to IPCI’s crowdfunding campaign today! Proceeds will help build the Peyote Nursery & Welcome Center, lease land from ranchers to reconnect Indigenous communities with spiritual and sustainable harvest of the Medicine, and fund Indigenous pilgrimages to the Peyote gardens to deepen their relationship to the Medicine through educational programming.

Continue Reading

Corrections to Misinformation Being Spread about MAPS and IPCI

I’m writing in my capacity as a board member of MAPS and supporter of the Indigenous Peyote Conservation Initiative (as well as Decriminalize Denver, Decriminalize Nature DC, DN Seattle, Measures 109, 110 and the Plant Medicine Healing Alliance in Oregon).  Decriminalize Nature (DN) leadership is engaging in the same conspiracy smear campaign against MAPS over personal possession limits in SB519,

Continue Reading

Towards a More Rational and Compassionate Drug Policy

I began this blog on my return from going deep with ibogaine with my friends at Iboga Quest in Tepotzlan, Mexico. What incredible medicine, especially for folks in the throes of opiate addiction. Ibogaine interrupts withdrawal and resets the dopamine system, while precipitating an intense “life review” psychedelic experience, giving insights into behavior, thought patterns, and underlying traumas.

Continue Reading

California’s Psychedelic Decrim Bill SB 519 Marches On!

After a rollercoaster ride, Senator Scott Wiener’s SB 519 is through the California Assembly Health Committee with an 8 to 4 vote. In order to make this happen, Senator Wiener’s office advised that we would have to drop ketamine and adopt personal possession limits. There was fundamental disagreement with Decriminalize Nature (DN) on whether it was politically possible to convince the Health Committee to go for no limits.

Continue Reading

West Coast Psychedelic Update

It’s incredible to see all the amazing progress we’re making in psychedelic policy on the West Coast—below are updates on major efforts we’ve been helping organize. In California, we’re marching towards decriminalizing psychedelics with Senator Scott Wiener’s Senate Bill 519. The policy includes both plant medicines and synthetics, sans peyote per the National Council of the Native American Church.

Continue Reading

Psychedelics at a Crossroads: We Need Constructive Not Extractive Capital

In her recent thoughtful and well-researched article for Vice, Shayla Love asked, “Is it possible to create an ethical psychedelics company?” A lot of focus in the psychedelics space over the last few months has centered around the unethical behavior of select companies—David himself has weighed in. Our take is that it’s not only possible to create an ethical psychedelics company,

Continue Reading

Sounding the Alarm on Compass’s Interference with Oregon’s Psilocybin Therapy Program

It’s time to publicly call out the for-profit psychedelic pharma company Compass Pathways, for their monopolistic and shady behavior. This Vice article, “Can a Company Patent the Basic Components of Psychedelic Therapy”, details their recent attempts to patent a clinical setting with mood lighting, soft furniture, subdued colors and a good sound system. This was after they tried to patent psilocybin synthesis in a way that would occupy the field and prevent awesome nonprofit drug development companies like Usona and B-more,

Continue Reading